D-0434-2025 Class II Terminated

Recalled by KENIL HEALTHCARE PRIVATE LIMITED — Ta. Kadi, District Mehsana, N/A

FDA drug recall D-0434-2025 was initiated by KENIL HEALTHCARE PRIVATE LIMITED on Apr 24, 2025 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Feb 19, 2026). Affected quantity: 216,720 Tubes.

Recall details

Product Type
Drugs
Report Date
May 28, 2025
Initiation Date
Apr 24, 2025
Termination Date
Feb 19, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
216,720 Tubes

Product description

Maximum Security, Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint Flavor, NET WT 1.5 OZ (43 g) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-132-04

Reason for recall

CGMP Deviations

Distribution pattern

DE and NC

Code information

Lot B0013, Exp Date: 05/31/2026; Lot B0018, Exp Date: 06/30/2026; Lot B0053, B0054, Exp Date: 07/31/2026; Lot B0090, B0091, B0092, B0093, B0094, B0095, B0096, B0097, B0098, B0099, B0100, B0101, Exp Date: 09/30/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0434-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0434-2025. Report a data issue: hello@regdatalab.com.